查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405908

美國和日本富血小板血漿市場規模、佔有率和趨勢分析報告：按類型、按應用、按最終用途、按國家、細分市場預測，2024-2030 年

U.S. And Japan Platelet Rich Plasma Market Size, Share & Trends Analysis Report By Type, (Pure Platelet Rich Plasma, Leukocyte Rich Platelet Rich Plasma), By Application, By End-use, By Country, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

美國和日本富血小板血漿市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，美國和日本富血小板血漿市場規模將達到3.4845億美元，2024年至2030年複合年成長率為10.15%。 。

美國和日本的富血小板血漿（PRP）市場受到整形外科疾病和運動傷害發病率增加、整容手術數量增加以及富血小板血漿醫療應用不斷擴大的推動。此外，越來越多的關於使用富含血小板血漿的創傷治療的實證研究進一步推動了整體市場的成長。

近年來，富含血小板的血漿產品在治療肌肉骨骼疾病、整形外科疾病和運動傷害方面的應用越來越普及。多項研究發現，增加 PRP 中生長因子的濃度可能會加速癒合過程。 PRP 與幹細胞和支架一起，是該領域本土產品的主要來源，並已被證明是癒合過程的真正先兆。美國疾病預防控制中心的資料顯示，美國的體育運動參與度持續增加。美國約有3000萬兒童和青少年參與運動，增加了年輕運動員運動傷害的風險。因此，整形外科疾病和運動傷害發病率的增加將對富血小板血漿治療程序的需求產生正面影響。

整容手術的增加將推動對富含血小板的血漿產品的需求。例如，根據 ASPS 的數據，過去四年，PRP 在化妝品中的使用量增加了 25%。此外，美國和日本擴大採用整容手術，預計這將在研究期間為市場提供利潤豐厚的機會。根據美國臉部整形與重組外科學會 (AAFPRS) 年度調查，注射劑是 2018 年臉部整形外科醫師最常用的治療選擇。美國在整容手術和微創手術上的高額支出也推動了富含血小板的血漿市場。根據美容協會的資料，2022 年美國在微創和整容手術上的支出約為 118 億美元，與前一年同期比較成長 2%。

富含血小板血漿的效用在美容和皮膚科中越來越受歡迎。儘管市售系統提供即用型無菌 PRP 懸浮液，但這些產品的高成本使醫療專業人員難以大規模部署 PRP套件。與其他治療方法相比，PRP 注射的高成本是患者和臨床醫生的主要擔憂。此外，由於缺乏支持 PRP 治療的證據，保險不承保這些產品。美國整形外科醫師學會指出，PRP 結果因患者而異，取決於患者的癒合能力。因此，與這些產品相關的成本可能會在預測期內阻礙市場。

美國和日本富血小板血漿市場報告亮點：

  • 從類型來看，純富血小板血漿細分市場佔據主導地位，2023年收益佔有率為51.24%，原因是純富血小板血漿因其優勢而採用率較高，並且在各個治療領域的應用不斷擴大。
  • 從應用來看，預計雜項業務在預測期內將以最快的複合年成長率成長。
  • 根據最終用途，醫院細分市場在 2023 年佔據市場最大收益佔有率。用於美容目的的 PRP 治療日益受到重視是推動該細分市場成長的關鍵因素。由於診所數量的增加和醫療旅遊業的成長，預計診所部門在預測期內將以最快的複合年成長率成長。
  • 美國市場的主導地位是由於監管支持以及許多專注於開發新的 PRP 製備系統的主要製造商在當地進行擴張等因素造成的。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國和日本富血小板血漿市場變數、趨勢和範圍

  • 美國與日本富血小板血漿市場陣容展望
    • 母市場展望
    • 輔助設備市場
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 美國和日本富血小板血漿市場分析工具
    • 波特五力分析
    • PESTLE分析
    • 主要觀點觀點分析
    • 市場機會分析
    • 買家認知調查
    • 主要觀點觀點分析

第 4 章美國和日本富血小板血漿市場 - 按類型細分分析，2018-2030 年

  • 美國和日本富血小板血漿（Prp）市場：類型變異分析
    • 純PRP
    • 多白血球RP
    • 其他

第 5 章美國與日本富血小板血漿市場 – 按應用細分分析，2018-2030 年

  • 美國和日本富血小板血漿（Prp）市場：應用變化分析
    • 整形外科
    • 其他

第6章美國和日本富血小板血漿市場 - 按最終用途細分的細分分析，2018-2030 年

  • 美國和日本富血小板血漿 (Prp) 市場：最終用途變化分析
    • 醫院
    • 診所
    • 其他

第7章美國和日本的富血小板血漿（PRP）市場：國家估計和趨勢分析

  • 美國
    • 主要國家趨勢
    • 美國富含血小板血漿
    • 競爭場景
    • 法律規範
    • 贖回場景
    • 日本

第8章競爭形勢

  • 公司分類
  • Participants'Overview
  • 財務績效
  • 產品基準評效
  • 2023 年公司市場佔有率分析
  • 策略規劃
    • 擴張
    • 合作
    • 新產品發布
    • 獲得
    • 其他
  • List Of Emerging Companies
    • Johnson & Johnson Services, Inc.
    • Arthrex, Inc.
    • EmCyte Corporation
    • Dr. PRP USA LLC
    • Juventix Regenerative Medical, LLC
    • Terumo Corporation
    • Zimmer Biomet
    • Stryker
    • Apex Biologix
    • Celling Biosciences, Inc.
    • Factor Medical, Inc.
    • CAREstream America
    • Royal Biologics.

第9章 結論

Product Code: GVR-4-68040-179-8

U.S. And Japan Platelet Rich Plasma Market Growth & Trends:

The U.S. and Japan platelet rich plasma market size is anticipated to reach USD 348.45 million by 2030, registering a CAGR of 10.15% from 2024 to 2030, according to a new report by Grand View Research, Inc. The U.S. and Japan platelet rich plasma (PRP) market is driven by increasing incidence of orthopedic disorders and sports injuries, growing number of cosmetic surgeries, and expanding medical application of platelet rich plasma. Moreover, increasing evidence-based studies for platelet rich plasma-based wound healing are further propelling growth of overall the market.

The application of platelet rich plasma products in treatment of musculoskeletal conditions, orthopedic disorders, and sports injuries has become more prevalent over recent years. Several research studies have observed that an increased concentration of growth factors in PRP can potentially accelerate healing process. PRP has proven to be a major source of autologous products in the field and a true precursor for healing process along with stem cells & scaffold. According to U.S. CDC data, participation of individuals in sports in the U.S. is continuously rising. Around 30 million children and adolescents in the U.S. participate in sports, which increases risk of sports injuries among young athletes. Therefore, the rise in incidence of orthopedic disorders and sports injuries positively impacts demand for platelet rich plasma treatment procedures.

An increase in cosmetic surgeries drives demand for platelet rich plasma products. For instance, according to the ASPS, a 25% rise in use of PRP in cosmetics was observed in the past 4 years. Moreover, increasing adoption of cosmetic surgeries in the U.S. and Japan is expected to offer lucrative opportunities for the market during the study period. As per an annual survey of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), injectables became the most adopted treatment option by facial plastic surgeons in 2018. Large spending by Americans on cosmetic surgeries and minimally invasive procedures also drives platelet rich plasma market. According to the Aesthetic Society data, Americans spent approximately USD 11.8 billion on minimally invasive and cosmetic surgery procedures in 2022, reporting an increase of 2% over previous year.

The utility of platelet rich plasma is gaining popularity in aesthetics and dermatology. The commercially marketed systems provide ready-to-apply sterile PRP suspensions; however, high cost associated with these products makes it difficult for healthcare professionals to deploy PRP kits on a large scale. The higher cost of PRP injection as compared to other treatments is a major concern for patients and clinicians. Moreover, insurance policies do not cover these products due to a lack of supportive evidence for PRP therapies. The American Academy of Orthopedic Surgeons stated that PRP results differ from patient to patient, depending on healing capabilities. Thus, cost associated with these products is likely to impede the market over the forecast period.

U.S. And Japan Platelet Rich Plasma Market Report Highlights:

  • Based on type, the pure platelet rich plasma segment dominated the market with a revenue share of 51.24% in 2023 owing to high adoption of pure platelet rich plasma because of its advantages and expanding applications across various therapeutic areas
  • Based on application, the other segment is expected to grow at fastest CAGR over the forecast period
  • Based on end-use, the hospitals segment held the largest revenue share of the market in 2023. Increasing priority of PRP treatment for aesthetic purposes is a significant factor driving growth of this segment. Clinics segment is expected to grow at fastest CAGR over forecast period owing to rising number of clinics and growing medical tourism
  • U.S. dominated the market owing to factors such as supportive regulatory authorities and local presence of many leading manufacturers that focus on developing novel PRP preparation systems

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Regional Scope
    • 1.1.2 Market Definitions
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Objectives
    • 1.2.1 Objective - 1
    • 1.2.2 Objective - 2
    • 1.2.3 Objective - 3
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1 Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom-Up Approach
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Type And Application Segment Snapshot
  • 2.3 End-Use Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 U.S. And Japan Platelet Rich Plasma Market Variables, Trends, And Scope

  • 3.1 U.S. And Japan Platelet Rich Plasma Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Rise In Incidence Of Orthopedic Disorders And Sports Injuries
      • 3.2.1.2 Increasing Cosmetic Surgeries
      • 3.2.1.3 Expanding Medical Applications Of Prp
      • 3.2.1.4 Increasing Evidence-Based Studies For Prp-Based Wound Healing
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Costs Associated With Prp Products
  • 3.3 U.S. And Japan Platelet Rich Plasma Market Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 Pestle Analysis
    • 3.3.3 Key Opinion Perspective Analysis
    • 3.3.4 Market Opportunity Analysis
    • 3.3.5 Buyer Perception Studies
    • 3.3.6 Key Opinion Perspective Analysis

Chapter 4 U.S. And Japan Platelet Rich Plasma Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1 U.S. And Japan Platelet Rich Plasma (Prp) Market: Type Movement Analysis
    • 4.1.1 Pure Prp
      • 4.1.1.1 Orthopedics
      • 4.1.1.1.1 Sports Medicine
      • 4.1.1.1.2 Spine
      • 4.1.1.1.3 Trauma
      • 4.1.1.1.4 Foot And Ankle
      • 4.1.1.1.5 Joint Reconstruction
    • 4.1.2 Leukocyte-Rich Rich Prp
      • 4.1.2.1 Orthopedics
      • 4.1.2.1.1 Sports Medicine
      • 4.1.2.1.2 Spine
      • 4.1.2.1.3 Trauma
      • 4.1.2.1.4 Foot And Ankle
      • 4.1.2.1.5 Joint Reconstruction
    • 4.1.3 Others
      • 4.1.3.1 Orthopedics
      • 4.1.3.1.1 Sports Medicine
      • 4.1.3.1.2 Spine
      • 4.1.3.1.3 Trauma
      • 4.1.3.1.4 Foot And Ankle
      • 4.1.3.1.5 Joint Reconstruction

Chapter 5 U.S. And Japan Platelet Rich Plasma Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1 U.S. And Japan Platelet Rich Plasma (Prp) Market: Application Movement Analysis
    • 5.1.1 Orthopedics
      • 5.1.1.1 Sports Medicine
      • 5.1.1.2 Spine
      • 5.1.1.3 Trauma
      • 5.1.1.4 Foot And Ankle
      • 5.1.1.5 Joint Reconstruction
    • 5.1.2 Others

Chapter 6 U.S. And Japan Platelet Rich Plasma Market - Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1 U.S. And Japan Platelet Rich Plasma (Prp) Market: End-Use Movement Analysis
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Others

Chapter 7 U.S. And Japan Platelet Rich Plasma (Prp) Market: Country Estimates And Trend Analysis

  • 7.1. U.S.
    • 7.1.1 Key Country Dynamics
    • 7.1.2 U.S. Platelet Rich Plasma (Prp) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.1.3 Competitive Scenario
    • 7.1.4 Regulatory Framework
    • 7.1.5 Reimbursement Scenario
    • 7.1.6 Japan
      • 7.1.6.1 Key Country Dynamics
      • 7.1.6.2 Japan Platelet Rich Plasma (Prp) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 7.1.6.3 Competitive Scenario
      • 7.1.6.4 Regulatory Framework
      • 7.1.6.5 Reimbursement Scenario

Chapter 8 Competitive Landscape

  • 8.1 Company Categorization
  • 8.2 Participants' Overview
  • 8.3 Financial Performance
  • 8.4 Product Benchmarking
  • 8.5 Company Market Share Analysis, 2023
  • 8.6 Strategy Mapping
    • 8.6.1 Expansion
    • 8.6.2 Collaborations
    • 8.6.3 New Product Launches
    • 8.6.4 Acquisitions
    • 8.6.5 Others
  • 8.7 List Of Emerging Companies
    • 8.7.1 Johnson & Johnson Services, Inc.
    • 8.7.2 Arthrex, Inc.
    • 8.7.3 EmCyte Corporation
    • 8.7.4 Dr. PRP USA LLC
    • 8.7.5 Juventix Regenerative Medical, LLC
    • 8.7.6 Terumo Corporation
    • 8.7.7 Zimmer Biomet
    • 8.7.8 Stryker
    • 8.7.9 Apex Biologix
    • 8.7.10 Celling Biosciences, Inc.
    • 8.7.11 Factor Medical, Inc.
    • 8.7.12 CAREstream America
    • 8.7.13 Royal Biologics.

Chapter 9 Conclusion

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Growth factors involved in stages of wound healing
  • Table 4 Growth factors involved in wound healing with their origin
  • Table 5 Use of PRP in wound management
  • Table 6 Randomized controlled trials: PRP-based wound healing
  • Table 7 Some of the prominent manufacturers operating in pure PRP market
  • Table 8 Some of the hospitals offering PRP treatment for different applications
  • Table 9 Some of the PRP service providers in Japan
  • Table 10 Key companies undergoing expansions
  • Table 11 Key companies undergoing collaborations
  • Table 12 Key companies undergoing new product launches
  • Table 13 Key companies undertaking acquisitions
  • Table 14 Key companies undertaking other activities
  • Table 15 Key companies undertaking other activities
  • Table 16 China immunohistochemistry market, by type, 2018 - 2030 (USD Million)
  • Table 17 China immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 18 China immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Japan immunohistochemistry market, by type, 2018 - 2030 (USD Million)
  • Table 20 Japan immunohistochemistry market, by application, 2018 - 2030 (USD Million)
  • Table 21 Japan immunohistochemistry market, by end use, 2018 - 2030 (USD Million)  

List of Figures

  • Fig. 1 U.S. and Japan Platelet rich plasma market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and application segment snapshot
  • Fig. 10 End-use segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Global platelet rich plasma (PRP) market value, 2023 (USD Million)
  • Fig. 13 Market dynamics
  • Fig. 14 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
  • Fig. 15 Incidence of arthritis in U.S., by age
  • Fig. 16 Benefits of PRP treatment in cosmetic facial procedures
  • Fig. 17 Common minimal invasive procedures in 2019, U.S.
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 PESTLE analysis
  • Fig. 20 Platelet rich plasma market: End-use outlook and key takeaways
  • Fig. 21 U.S. and Japan Platelet rich plasma (PRP) market: Type movement analysis
  • Fig. 22 Pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
  • Fig. 24 Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
  • Fig. 25 Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
  • Fig. 26 Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
  • Fig. 27 Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle, 2018 - 2030 (USD Million)
  • Fig. 28 Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction, 2018 - 2030 (USD Million)
  • Fig. 29 Leukocyte-rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
  • Fig. 31 Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
  • Fig. 32 Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
  • Fig. 33 Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
  • Fig. 34 Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle , 2018 - 2030 (USD Million)
  • Fig. 35 Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction , 2018 - 2030 (USD Million)
  • Fig. 36 Others PRP market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. and Japan Platelet rich plasma (PRP) market: Application outlook and key takeaways
  • Fig. 44 U.S. and Japan Platelet rich plasma (PRP) market: Application movement analysis
  • Fig. 45 Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
  • Fig. 46 Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
  • Fig. 47 Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
  • Fig. 48 Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
  • Fig. 49 Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle, 2018 - 2030 (USD Million)
  • Fig. 50 Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction, 2018 - 2030 (USD Million)
  • Fig. 51 Platelet Rich Plasma (PRP) market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 52 Percentage of adult population dental clinic visits, U.S.
  • Fig. 53 U.S. and Japan Platelet rich Plasma (PRP) market: End-use outlook and key takeaways
  • Fig. 54 U.S. and Japan Platelet rich plasma (PRP) market: End-use movement analysis
  • Fig. 55 Platelet rich plasma (PRP) market for hospitals, 2018 - 2030 (USD Million)
  • Fig. 56 Platelet rich plasma (PRP) market for clinics, 2018 - 2030 (USD Million)
  • Fig. 57 Platelet rich plasma (PRP) market for other end uses, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 U.S. Platelet Rich Plasma (PRP) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Japan Platelet Rich Plasma (PRP) market estimates and forecast, 2018 - 2030 (USD Million)